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Objective: Clinical and laboratory studies have documented changes in cerebrovascular resistance after hypo-
thermic circulatory arrest, both with and without adjunctive cerebral perfusion modalities. This study was de-
signed to clarify whether these changes are due to cerebral edema, resistance vessel abnormalities, or
alterations in the cerebral microcirculation.
Methods: Four mature swine underwent hypothermic circulatory arrest for 60 minutes, and 7 mature swine un-
derwent cold cerebral perfusion for 60 minutes to simulate antegrade selective perfusion. All were rewarmed and
weaned from cardiopulmonary bypass. Pial vascular diameter and reactivity were measured in vivo through a cra-
nial window and ex vivo in an organ chamber; cerebral microvascular endothelium was studied in culture for re-
lease of vasoactive mediators. Cerebral water content was recorded.
Results: Cold perfusion caused pial arteriole and venule constriction, whereas hypothermic circulatory arrest
alone caused pial arteriole and venule dilatation. Cold perfusion caused a temporal loss of endothelium-dependent
vasodilatation, most notably to bradykinin. Hypothermic circulatory arrest caused a loss of nitric oxide-mediated
endothelium-dependent vasodilatation. Endothelium-independent vasoreactivity remained intact in both groups.
Endothelial cells from the cold group had a vasoconstrictive secretory phenotype, whereas endothelial cells from
the hypothermic circulatory arrest group had a vasodilatory phenotype. Cerebral water content was the same in
both groups.
Conclusion: The increase in cerebrovascular resistance observed after cold cerebral perfusion is caused by resis-
tance vessel constriction and may be promoted by an altered microcirculation. Hypothermic circulatory arrest




PNeurologic complication after hypothermic circulatory ar-
rest (HCA) occurs from inadequate substrate delivery with
ongoing substrate metabolism.1,2 Selective cold cerebral
perfusion was developed to prolong the safe period of
HCA by providing nutritive blood flow in the setting of con-
tinuing cerebral metabolism. Continuous cold perfusion,
however, is associated with elevated cerebral vascular resis-
tance after cardiopulmonary bypass (CPB),1,3,4 which could
contribute to neurologic injury in the vulnerable period early
after cardiovascular operation. HCA alone has a variable ef-
fect on cerebral vascular resistance after separation from
CPB.5-8 It is unclear whether the increase in cerebral vascu-
lar resistance after cold perfusion is related to cerebral
edema, arteriole constriction, or an abnormality in the cere-
bral microcirculation.
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doi:10.1016/j.jtcvs.2008.08.022The Journal of Thoracic andThis study was designed to directly measure the effect of
both continuous cold cerebral perfusion and HCA alone on
cerebral water content, the cerebral resistance vessel diame-
ter and reactivity, and the secretory phenotype of the cere-
bral microcirculation. It was hypothesized that continuous
cold perfusion is associated with a cerebral vasoconstrictive
phenotype when compared with HCA alone. To test this hy-
pothesis, cerebral cortical water content, the in vivo response
of pial arterioles and their in vitro reactivity in an organ
chamber, and the secretory profile of the cerebral microvas-
cular endothelium were measured during and after continu-
ous cold perfusion and HCA.
MATERIALS AND METHODS
Animal Preparation
Mature swine (35–65 kg) were premedicated with ketamine (10 mg/kg
intramuscularly), and anesthesia was induced with 4% isoflurane. Animals
were then intubated orally and ventilated with a mixture of room air and
0.5% to 2.0% isoflurane. Ventilation was adjusted to maintain normocap-
nia with an end-tidal CO2 analyzer (Datex 223 CO2 Monitor, Puritan-
Bennett Corp, Wilmington, Mass) and arterial blood gas monitor (2500
Co-oximeter, Ciba-Corning Diagnostics Corporation, Medfield, Mass).
The PaO2 was maintained between 80 and 100 mm Hg. Core body temper-
ature was monitored with a thermistor—tipped vascular catheter (7.5F,
American Edwards Labs, Irvine, Calif) and a nasopharyngeal temperature
probe. A servomechanically controlled heating pad was used to maintain
normothermia before and after CPB. The femoral vessels were cannulated
for blood sampling, fluid administration, and mean arterial pressureCardiovascular Surgery c Volume 137, Number 2 459





CPB ¼ cardiopulmonary bypass
CSF ¼ cerebrospinal fluid
DMEM ¼ Dulbecco modified Eagle medium
HCA ¼ hypothermic circulatory arrest
MAP ¼ mean arterial pressure
NO ¼ nitric oxide
PSS ¼ physiologic saline solution
(MAP) and central venous pressure monitoring. Lactated Ringer’s solution
was administered to compensate for evaporative losses and third spacing.
The rate was adjusted to maintain urine output greater than 0.5 mL/kg/h
and MAP between 55 and 70 mm Hg. A mini-laparotomy was performed
for bladder catheterization for measurement of urine output.
The animals were placed in the prone position with their heads stabilized
on a padded frame. A T-shaped scalp incision was performed to expose the
skull for placement of a 10-mm closed cranial window for visualization of
pial vessels.9 The windowwas placed over the left parietal cortex and equip-
ped with 2 openings to serve as ports for infusion of vasoactive drugs and
artificial cerebrospinal fluid (CSF; Naþ 150 mEq/L, Kþ 3 mEq/L, Ca2þ 2.5
mEq/L, Mg2þ 1.2 mEq/L, Cl 132 mEq/L, glucose 3.7 mmol/L, urea 6
mmol/L, and HCO3
 25 mEq/L). The artificial CSF was equilibrated with
gas containing 6.5% oxygen, 6.0% carbon dioxide, and 87.5% nitrogen
at 37C to give gas tensions and pH in the normal range for CSF.
Access for CPBwas performed through a left thoracotomy. Heparin (300
U/kg) was administered, and the ascending aorta was cannulated with a 16F
arterial cannula (CR Bard Inc, Haverhill, Mass). The right atrial appendage
was cannulated with a 24F right-angle cannula (Edwards Lifescience LLC,
Irvine, Calif). The CPB circuitry included a membrane oxygenator, a cardi-
otomy reservoir, and an arterial filter (Medtronic, Minneapolis, Minn). CPB
flowwas initiated at 100mL/kg/min and adjusted to maintainMAP between
55 and 60 mm Hg. The alpha-stat pH management strategy was used. The
degree of anticoagulation was monitored with activated clotting times.
In Vivo Diameter Studies
Two to four pial arterioles and venules (60–250 mm in diameter) were
selected for observation over the left hemisphere at 403 magnification us-
ing an OpMi 1 stereomicroscope (Carl Zeiss, Oberkochen, West Germany).
Vessel diameters were measured with an image-splitting eyepiece (Vick-
er’s, AEI Imaging Splitting Eyepiece,Woburn,Mass). After recording base-
line diameter measurements, 5 mL of 107 mol/L acetylcholine (Ach)
solution (Sigma Chemical, St Louis, Mo) was infused under the window
for assessment of endothelium-dependent vasodilatation. Ach acts on the
endothelium via muscarinic receptor-mediated release of nitric oxide (NO).
Concentrations of 107 to 108 mol/L cause dilatation of pial arterioles to
110% to 120% of baseline.10 Higher concentrations of Ach act directly on
the smooth muscle cell to cause contraction, overriding the endothelial cell
mediated vasodilatory response. The direct smooth muscle effect can also
occur when the receptor-mediated endothelial cell response is dysfunc-
tional. After completion of diameter measurements, 5 mL of artificial
CSF was infused to remove the Ach and allow vessels to return to their orig-
inal diameters. Five milliliters of 107 mol/L sodium nitroprusside (Sigma
Chemical, St Louis, Mo) was then infused to assess endothelium-indepen-
dent vasodilatation, followed by washout with artificial CSF.
Experimental Protocol
After completion of the skull preparation, the animals were left undis-
turbed for 30 minutes before performing baseline measurements. Animals460 The Journal of Thoracic and Cardiovascular Suwere then cooled for 30 minutes on CPB to 18C and randomized to either
COLD perfusion (n ¼ 7), consisting of an additional 60 minutes of perfu-
sion at 18C, or 60 minutes of HCA (n ¼ 4). All animals underwent aortic
crossclamping and received 300 mL of cold crystalloid cardioplegia, fol-
lowed by placement of an ice pack on the heart. After the period of cold per-
fusion or HCA, animals were rewarmed to 37C over 60 minutes, separated
from CPB, and allowed to perfuse normally for 60 minutes before sacrifice.
Pial vessel measurements were taken at baseline, after 90 minutes of cold
perfusion (COLD group only), after 60 minutes of rewarming, and 60 min-
utes after separation from CPB.
The animals were euthanized with a concentrated potassium solution un-
der anesthesia, and brains were removed under sterile conditions. A portion
of grey matter from the left hemisphere was placed in cold Hank’s balanced
salt solution (GIBCO, Grand Island, NY) for isolation of cerebral endothe-
lial cells. A second piece of cortical grey matter was weighed, dried for 12
hours at 80C, reweighed, and analyzed for cortical water content [(wet
weightdry weight/wet weight)] 3 100. The remaining portion of the left
hemisphere was placed in oxygenated cold physiologic saline solution
(PSS; 4C, 95%O2, 5%CO2) and transported to the laboratory for isolation
of pial arterioles.
This study was approved by the Institutional Animal Care and Use Com-
mittee at the University of Vermont, and all animals were handled in a hu-
mane manner in compliance with the ‘‘Guide for the Care and Use of
Laboratory Animal Resources’’ developed by the Institute of Laboratory
Animal Resources.
In Vitro Diameter Studies
Pial resistance-size arteries (150–350 mm in diameter) were identified
and removed from the left hemisphere under oxygenated cold PSS and can-
nulated on glass pipettes, mounted in a 5-mL myograph chamber (Living
Systems Instruments, Burlington, Vt), and bathed in aerated PSS (20%
O2, 5% CO2, 75% N2) at 37
C and pH 7.4. Diameters were measured
with video edge detection equipment and recorded with data acquisition
software (DI-700 withWinDaq waveform recording software, Dataq Instru-
ments; Akron, Ohio). The vessels were pressurized to 20 mm Hg and al-
lowed to equilibrate in a no-flow state using a burette manometer filled
with PSS. Tissue viability was assessed by replacement of NaCl with 60
mmol/L KCL in PSS.
Vessels were discarded if the initial contraction was less than 40% of
resting diameter, indicating nonviability. After washout with PSS and return
to resting diameter, intravascular pressure was increased in stepwise fashion
to assess for development of myogenic tone, which was defined as a percent
decrease relative to the fully dilated diameter at a given intravascular pres-
sure.11
Sequential application of increasing concentrations of Ach solution (109
to 105 mol/L in PSS) was performed. A period of 15 minutes was main-
tained between washouts to allow for equilibration. Vessel diameter was re-
corded before and after the addition of each solution, and percent change
from baseline was recorded. Bradykinin solution (107 mol/L) was then ap-
plied for further assessment of endothelium-dependent vasodilatation. Se-
quential application of a series of increasing concentrations of the
endothelium-independent vasodilator pinacidil (108 to 105 mol/L in
PSS) was then applied and diameter measurements were recorded. Finally,
diltiazem solution (53 105 mol/L in PSS, devoid of calcium) was added to
establish the fully dilated diameter. Because of varying vessel sizes, diam-
eter changes are expressed as percent change from baseline.
Cell Culture
Cortical gray matter was minced, placed in 0.01% type I collagenase
(GIBCO) for 15 minutes, and followed by neutralization with (Dulbecco
modified Eagle medium) DMEM (GIBCO) and filtration through mesh.
An equal volume of DMEMwas added, and the suspension was centrifuged
at 1500g for 10 minutes. The pellet was resuspended in 15 mL of DMEM
(supplemented with 20% fetal bovine serum, neomycin, and glutamine)rgery c February 2009
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Groups 0 h P 1.5 h P 2.5 h P 3.5 h P
MAP COLD 70  3 .55 56  1 - 57  2 .65 64  3 .12
HCA 67  3 - - - 55  4 - 56  2 -
HR COLD 117  7 .53 - - 120  16 .48 115  8 .29
HCA 110  4 - - - 109  6 - 99  11 -
CVP COLD 8  0.5 .007 6  1 - 7  1 .69 13  1 .02
HCA 11  2 - - - 8  1 - 17  2 -
TEMP COLD 37  0.5 .47 18  0.5 .39 36  0.5 .004 35  0.5 .15
HCA 37  0.5 - 17  0.5 - 38  0.5 - 36  0.5 -
MAP,Mean arterial pressure; HR, heart rate; CVP, central venous pressure; TEMP, temperature in degrees centigrade; COLD, continuous cold perfusion; HCA, hypothermic cir-
culatory arrest. 0 h¼ baseline values before CPB; 1.5 h ¼ 1.5 h of continuous cold cerebral perfusion in the COLD group and 30 min of cold perfusion plus 60 min of circulatory
arrest in the HCA group; 2.5 h ¼ completion of rewarming period on CPB; 3.5 h ¼ 1 h after separation from CPB.C
S
Pand plated on 100 mm2 tissue culture dishes (Benton Dickinson, Lincoln
Park, NJ). Dishes were placed in a humidified environment at 37C with
5%CO2. Themedia was changed after 3 days and every 48 hours thereafter.
The cells were passed at confluence and seeded in 25 cm2 tissue culture
flasks (Benton Dickinson) and propagated in DMEM. Cells were character-
ized as endothelium by growth pattern, binding of Bandeiraea simplicifolia
lectin (Sigma) and Factor VIII/vWF antibody (DAKO, Carpinteria, Calif),
and by the absence of binding of glial fibrillatory acidic protein (Sigma).
Early passage (Passage 2) cells were studied in serum free media. Con-
ditioned media was collected at 2, 16, and 24 hours and stored at80C, and
subsequently assayed for prostacyclin (6-keto-PGF1a enzyme-linked immu-
nosorbent assay, Caymen Chemical, Ann Arbor, Mich), endothelin (Immu-
nometeric Assay System, Caymen), and NO (Nitrate/Nitrite Fluorometric
Assay, Caymen). Results were standardized to cell count and total protein
(BCA Protein Assay Reagent, Pierce, Rockford, Ill).
Statistical Analysis
Data are given as mean values  1 standard error of the mean. Differ-
ences between groups were tested using the unpaired Student t test. Differ-
ences within groups were tested using the paired Student t test.
RESULTS
Hemodynamic Parameters
Hemodynamic parameters and temperature are shown in
Table 1. Both the baseline and final central venous pressure
were higher in the HCA group. Core body temperature was
higher in the HCA group after rewarming, but normalized
relative to the COLD group after separation from CPB.
The flow rate during 60 minutes of COLD perfusion ranged
from 44 to 88 mL/kg/min with a mean of 65  13 mL/kg/
min.
There were no meaningful differences between groups in
total intravenous fluid volume infused or urine output (total
fluid: 8214  1741 mL COLD, 6150  11,224 mL HCA,
P ¼ .16; urine output: 2225  1310 mL COLD, 1425 
1213 mL HCA, P ¼ .11). There was no difference
between groups in cerebral cortical water content (COLD:
85%  12%, HCA: 85%  12%, P ¼ .97).
In Vivo Diameter Studies
Cold perfusion caused pial venule constriction that per-
sisted after rewarming and restoration of normal perfusion.
HCA was associated with venule dilatation after both re-The Journal of Thoracic andwarming and restoration of normal flow (Table 2). Continu-
ous cold perfusion was associated with pial arteriole
constriction that persisted after rewarming and separation
from CPB. In contrast, pial arteriole dilatation occurred
with rewarming and reperfusion after HCA (Table 2).
Endothelium-dependent vasodilatation with application
of Ach occurred in both groups at baseline. There was
a loss of endothelium-dependent vasodilatation in the
COLD group after 90 minutes of cold perfusion. Rewarming
was associated with a loss of Ach-induced dilatation in both
groups when compared with baseline values (P ¼ .02,
COLD; P¼ .07, HCA). The endothelium-dependent vasodi-
latory response in the COLD group normalized after separa-
tion from CPB but was blunted in the HCA group (Table 2).
The endothelium-independent vasodilatory response to so-
dium nitroprusside was preserved in both groups at baseline
and during and after separation from CPB (Table 2).
In Vitro Diameter Studies
Pial arteries in both groups failed to develop myogenic
tone in response to serial increases in intraluminal pressure.
There was no difference between groups in response to the
endothelium-independent vasodilator pinacidil. Vasodilata-
tion in response to application of Ach was not seen in either
group. Instead, vasoconstriction occurred in the HCA group
at lower concentrations of Ach, indicating endothelial cell
dysfunction and unopposed smooth muscle cell activation
(Table 3).
There was no meaningful difference in the endothelium-
independent vasodilatory response to diltiazem between
groups (COLD: 124%  19%, HCA: 126%  114%,
P¼ .88). Application of bradykinin produced vasodilatation
after HCA and vasoconstriction after cold perfusion (HCA:
118% 18%, COLD: 80% 19%, P¼ .02), implying re-
ceptor-mediated endothelial cell dysfunction in the COLD
group.
Cell Culture
Microvascular cerebral endothelial cells isolated from an-
imals exposed to continuous cold perfusion secreted moreCardiovascular Surgery c Volume 137, Number 2 461
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PTABLE 2. In vivo pial vessel diameter and reactivity
GROUP 0 h P 1.5 h P 2.5 h P 3.5 h P
Venule Diameter COLD 100 - 82  7 - 81  6 .01 66  5 .001
HCA 100 - - - 111  10 - 123  15 -
Arteriole Diameter COLD 100 - 87  5 - 85  4 .05 79  3 .09
HCA 100 - - - 110  17 - 93  7 -
Arteriole Ach
(% resting value)
COLD 113  3 .78 90  2* - 102  4y .53 121  7 .22
HCA 114  3 - - - 98  6z - 105  10 -
Arteriole SNP
(% resting value)
COLD 108  1 .45 112  3 - 109  3 .74 110  2 .70
HCA 110  2 - - 111  4 - 111  4 -
Ach, Acetylcholine reactivity; SNP, sodium nitroprusside reactivity; COLD, continuous cold perfusion; HCA, hypothermic circulatory arrest. 0 h¼ baseline value before CPB; 1.5
h¼ 1.5 h of continuous cold cerebral perfusion in the COLD group; 2.5 h¼ completion of rewarming period on CPB; 3.5 h¼ 1 h after separation from CPB. *P<.001. yP¼ .08.
zP ¼ .07 vs baseline.endothelin and less prostacyclin than animals undergoing
HCA. NO was not detected in either group (Table 4).
DISCUSSION
This study supports previous work that found a decrease
in cerebral resistance vessel diameter during continuous
cold cerebral perfusion.12 This study is unique in the finding
that the phenotypic changes occurring in resistance vessels
after both continuous cold perfusion and HCA persist after
separation from CPB and can be documented in both organ
and cell culture. The increase in cerebral vascular resistance
after cold perfusion is not caused by cerebral edema but is
caused by cerebral arteriole constriction. Intrinsic abnormal-
ities occurred in the endothelial control of resistance vessels
and in the vasoactive phenotype of the microcirculation dur-
ing and after CPB with both cold perfusion and HCA alone.
Given the importance of the endothelium in the autocrine
and paracrine control of small cerebral resistance vessels,
abnormalities in the cellular control of vessel diameter
should have a major impact on local and regional substrate
delivery.
Continuous cold perfusion caused pial arteriole and ve-
nule constriction. Endothelial-mediated arteriole dilatation
was impaired during cold perfusion and rewarming but re-
covered after a period of normal pulsatile perfusion. Others
have noted a loss of endothelial-mediated cerebral vasodila-tation during cold perfusion on CPB.12 Cerebral arterioles
isolated from the cold perfusion animals failed to undergo
NO-mediated vasodilatation, implying persistent endothe-
lial cell dysfunction. This was confirmed by a vasoconstric-
tive response to bradykinin. Bradykinin normally induces
vasodilatation in cerebral arterioles by activating endothelial
B2 receptors. Bradykinin can produce vasoconstriction by
stimulating B1 receptors on smooth muscle cells in the pres-
ence of dysfunctional or absent endothelium. Bradykinin is
also known to cause vasoconstriction in the presence of in-
ducible NO synthase in certain pathologic states.13 Future
studies could address the cold perfusion-induction of cere-
bral inducible NO synthase or the induction of cerebrovas-
cular bradykinin receptor re-distribution.
Endothelial cells isolated from the microcirculation of
the COLD group showed a constrictive secretory profile.
Endothelin secretion was greater in the COLD group when
compared with the HCA group. Endothelin is a potent endo-
thelial cell-derived cerebral vasoconstrictor. Pial arteriole
endothelial cells have a heightened responsiveness to endo-
thelin relative to systemic arterioles.14 Exposure of pial arte-
rioles to endothelin increases their contractile response to
hemolyzed blood products,15 such as those released during
CPB. Substances generated during CPB also induce the syn-
thesis of endothelin, and include thrombin, transforming
growth factor-ß, angiotensin II, and arginine vasopressin.16TABLE 3. In vitro pial arteriole reactivity
Pressure-induced change in diameter Pinacidil Acetylcholine
COLD HCA P COLD HCA P COLD HCA P
20 mm Hg 100 100 - 100 100 - 100 100 -
40 mm Hg 110  2 110  2 1.0
60 mm Hg 122  7 116  3 .55
80 mm Hg 125  11 120  10 .77
109 mol/L 100  1 94  4 .10
108 mol/L 99  2 101  1 .32 100  1 88  6 .02
107 mol/L 99  1 102  1 .09 98  4 92  1 .29
106 mol/L 103  1 105  2 .53 94  4 89  5 .41
105 mol/L 121  13 127  10 .78 93  4 88  3 .55
COLD, Continuous cold perfusion; HCA, hypothermic circulatory arrest.
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Time point
(in serum-free media) Group PGF (pg/105 cells) P PGF (pg/mg protein) P ET (pg/105 cells) P ET (pg/mg protein) P
2 h COLD 21  4 .53 0.13  0.01 .06 5.4  0.8 .02 0.03  0.009 .003
HCA 17  5 0.08  0.02 3.1  0.4 0.01  0.002
16 h COLD 46  8 .04 0.53  0.2 .23 13.2  1 .03 0.1  0.03 .13
HCA 121  32 0.3  0.08 10.0  0.8 0.06  0.007
24 h COLD 74  11 .03 0.59  0.09 .38 24.4  3 .12 0.2  0.04 .01
HCA 154  31 0.81  0.24 32.6  5 0.08  0.02
PGF, Prostacyclin; ET, endothelin; COLD, continuous cold perfusion; HCA, hypothermic circulatory arrest.C
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PHCA alone is known to induce endothelin-1 mRNA expres-
sion in pulmonary arteries and is associated with an increase
in the pulmonary vascular resistance.17
HCA was not associated with cerebral vasoconstriction.
Pial arterioles dilated after rewarming fromHCAand returned
to near baseline diameter after 60 minutes of normal pulsatile
perfusion. There was, however, a loss of endothelial-medi-
ated vasodilatation in vessels after rewarming, which did
not completely normalize after restoration of normal perfu-
sion. Arterioles isolated from HCA animals constricted with
application of Ach at doses that normally produce vasodilata-
tion, a finding also noted in the rewarming phase in vivo after
HCA. These findings indicate direct unopposed action ofAch
on the smooth muscle cell secondary to NO-related endothe-
lial cell dysfunction and are seen in other organ systems after
both HCA and hypothermic CPB.18,19 This may be related, at
least partially, to abnormal endothelial cell-neutrophil inter-
action20 or endothelial cell-platelet interaction.21
HCA was associated with a vasodilatory phenotype in
cultured microvascular endothelial cells, as evidenced by
up-regulation of prostacyclin secretion. Prostacyclin, a po-
tent vasodilator, is released from cerebral endothelial cells
and into the CSF during brain ischemia.22,23 Prostacyclin
release may serve to enhance cerebral blood flow to meet
metabolic demand and may, therefore, contribute to the va-
sodilatation seen in arterioles and venules during rewarming
from HCA alone. Similar findings have been noted after re-
suscitation from hemorrhagic shock.23 Vasodilatation after
rewarming from HCA could also represent a maladaptive re-
sponse known as luxury perfusion, a risk factor for embolic
stroke as speculated by some authors.5
NO was not detected in conditioned media from cerebral
endothelial cells in either group, and, as noted, NO-mediated
vasodilatation was absent in isolated cerebral arterioles.
Others have noted a cerebrovascular NO deficit after
HCA,24 and NO production by cerebral endothelial cells is
impaired after hemorrhage-induced cerebral ischemia.23
The direct smooth muscle response to vasodilators re-
mained intact in this study. However, there was a loss of
myogenic tone to stepwise application of intraluminal pres-
sure in isolated arteries from both groups. This could signify
a loss of pressure autoregulation or a loss of spontaneous
vasomotion in cerebral arterioles, which could contributeThe Journal of Thoracic and Cto abnormalities in local cerebral oxygen delivery. Loss of
pressure autoregulation and dysfunctional endothelial cell-
mediated vasodilatory mechanisms may contribute to low
flow states after HCA7 and could predispose patients to neu-
rologic injury in the early hours after operation when hemo-
dynamic instability commonly occurs.
Despite the theoretic clinical advantage of antegrade cere-
bral perfusion over HCA alone, or retrograde cerebral perfu-
sion, findings of the current study suggest that cold cerebral
perfusion may cause intrinsic abnormalities in the cerebral
vasculature that could lead to low flow states early after op-
eration. In at least 1 clinical study antegrade cerebral perfu-
sion was associated with worse neurocognitive impairment
when compared with HCA alone.25 Others have shown
that antegrade perfusion at lower flow rates using mild to
moderate hypothermia improves clinical outcome.3,6,26-28
Lower flow rates and higher temperatures may limit the va-
soconstrictive response and endothelial cell dysfunction
seen with high flow rates and profound hypothermia, while
still providing nutritive blood flow.
Limitations
Nonselective antegrade cerebral perfusion was used in
this study. The cerebral flow rate is unknown. Higher flows
are known to induce vasoconstriction.29 Much lower flow
rates, however, have also been shown to increase cerebral
vascular resistance.7 Extrapolating from the adult human,
in whom 40% to 45% of systemic flow is delivered to the
upper body during CPB, it is conceivable that our model de-
livered upper body flow in the range of 18 to 35 mL/kg/min
(mean 26–29 mL/kg/min) based on our experimental sys-
temic flow rate during cold perfusion. In a recent porcine
study,30 MAP-dependent flow delivered into the isolated
aortic arch was 16 mL/kg/min at a MAP of 50 mm Hg and
34 mL/kg/min at a MAP of 70 mm Hg. It is reasonable to
presume that nonselective flow through the common bra-
chiocephalic trunk in our study (mean MAP 56 mm Hg dur-
ing COLD perfusion) was in the lower range of these flows,
making them clinically relevant.
Prolonged cooling before circulatory arrest and antegrade
perfusion is often performed to obtain isoelectric electroen-
cephalogram in anticipation of long arrest times. Systemic
cooling times are often in excess of 50 minutes, at perfusateardiovascular Surgery c Volume 137, Number 2 463
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Ptemperatures of 15C to 18C. The systemic cooling time in
this study of 30 minutes, followed by 60 minutes of contin-
uous flow, will fall into perfusion ranges used clinically,
most commonly during total arch replacement. These data,
however, may not have relevance to shorter periods of
cold perfusion, such as used in hemiarch replacement. Fi-
nally, it would be unwise to extrapolate these data to pediat-
ric patients, because both mature animals and the a-stat pH
management strategy were used in this study.
CONCLUSIONS
This work shows that the increase in cerebrovascular re-
sistance seen clinically after cold antegrade cerebral perfu-
sion is secondary to direct cerebral resistance vessel
constriction and suggests that the increase in resistance is as-
sociated with an endothelial cell vasoconstrictive phenotype
in both the resistance vessels and the microcirculation. The
increase in cerebrovascular resistance seen in some clinical
studies after HCA alone may not be directly due to resistance
vessel constriction but may be related to abnormal autoregu-
lation from endothelial cell dysfunction of NO-mediated va-
sodilatation, and this may be driven by ischemia. Both
modalities could place the cerebral vasculature at risk for in-
appropriate vasoconstriction early after operation in the set-
ting of unopposed vasoconstrictors released during CPB.
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